Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Cancer Research|April 23, 2009
Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasisSimone Barbero, Ainhoa Mielgo, Vicente Torres, et al.
Theranostics|January 8, 2019
CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolismRuifang Gao, Dan Li, Jing Xun, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2008
The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8Wolf Wrasidlo, Ainhoa Mielgo, Vicente A Torres, et al.
Molecular Biology of the Cell|April 9, 2025
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growthXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null MiceXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 12, 2018
PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent MannerRuifang Gao, Yanhua Liu, Dan Li, et al.
Cancer Biology & Therapy|March 18, 2010
Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical modelsColin Walsh, Isabelle Tanjoni, Sean Uryu, et al.
Blood|January 9, 2008
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factorLisette M Acevedo, Samuel Barillas, Sara M Weis, et al.
Molecular Biology of the Cell|October 17, 2008
Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse studyPaul A Rupp, Richard P Visconti, András Czirók, et al.
Oncotarget|September 30, 2015
A strategy to combine pathway-targeted low toxicity drugs in ovarian cancerJoe R Delaney, Chandni Patel, Katelyn E McCabe, et al.
Pageof 14